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Abstract (149 words) 
 
Copeptin, the C-terminal part of the arginine vasopressin precursor peptide, holds 
promise as a diagnostic and prognostic plasma biomarker in various acute clinical 
conditions. Factors influencing copeptin response in the critical care setting are only 
partially established and have not been investigated systematically. Using an in vivo 
infant ventilation model (Wistar rats, 14 days old), we studied the influence of 
commonly occurring stressors in critically ill children. In unstressed ventilated rats 
basal median copeptin concentration was 22 pmol/L. In response to respiratory 
alkalosis copeptin increased 5-fold, while exposure to hypoxemia, high PEEP, 
hemorrhage, and psycho-emotional stress produced a more than 10-fold increase. 
Additionally, we did not find a direct association between copeptin and acidosis, 
hypercapnia, and hyperthermia. Clinicians working in the acute critical care setting 
should be aware of factors influencing copeptin plasma concentrations. Moreover, our 
results do have implications for animal studies in the field of stress research.  
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1. Introduction 
Arginine vasopressin (AVP), also known as antidiuretic hormone (ADH), is a 
neurohypophysial hormone playing a key role in osmoregulation and water 
homeostasis. Moreover, non-osmotic release of AVP is described in adult patients 
with cardiovascular and renal diseases (Stoiser et al., 2006; Meijer et al., 2011), stroke 
(Katan et al., 2009), sepsis (Morgenthaler et al., 2007; Jochberger et al., 2009), and 
pneumonia (Müller et al., 2007). In contrast to AVP, the C-terminal part of 
provasopressin, copeptin, is both without known physiological activity and easy and 
robust to measure (Morgenthaler et al., 2006). Since copeptin is released equimolar to 
AVP, there is considerable interest in copeptin as a diagnostic and prognostic 
biomarker (Katan and Christ-Crain, 2010; Mellbin et al., 2010; Potocki et al., 2010). 
Ideally, biomarkers are surrogate markers for disease and its severity (Vasan, 2006). 
Recently, copeptin has also been shown to be a highly sensitive though minimally 
specific marker of fetal and neonatal stress (Wellmann et al., 2010; Schlapbach et al., 
2011; Benzing et al., 2011). As opposed to adults with inappropriately low AVP in 
septic shock, studies in children with septic shock did not find AVP deficiency 
(Leclerc et al., 2003; Lodha et al., 2006). Various reasons may account for this 
inconsistence; firstly, well known age-related differences in predisposing diseases, 
physiology, and management strategies; secondly, methodological issues since AVP 
measurement is cumbersome when compared to copeptin; finally, heterogeneity of 
critical care patients usually affected by more than one pathophysiological disorder 
making it difficult to allocate AVP response. 
Before implementing copeptin in the field of pediatric critical care, factors affecting 
its plasma concentration should be systematically investigated. Hence, the aim of this 
project was to study copeptin plasma concentrations in response to commonly 
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occurring stressors and to call for caution when elevated copeptin levels are measured 
and interpreted in pediatric critical care practice. Apart from the advantage of protocol 
standardization, using an in vivo experimental infant (non-neonatal) rat model allowed 
investigation of selected pathophysiological conditions that can generally not be 
examined and partitioned in the critical care context. We hypothesized that copeptin 
plasma concentration is affected by mechanical ventilation, hypovolemia, hypoxemia, 
acidosis, and hyperthermia. 
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2. Methods 
 
2.1 Animals 
Experimental protocols were approved by the cantonal authority of Zurich and were 
conducted in compliance with legal requirements and the Swiss Animal Welfare 
Legislation. Infant Wistar rats of either sex were purchased from Charles River 
Laboratories International, Inc. (Sulzfeld, Germany) at the age of ~7 days and were 
used for experimentation at the age of 14 days. Dams were provided food and water 
ad libitum and were kept under 12 h light dark cycles. 
 
2.2 Animal preparation before mechanical ventilation 
After brief inhalational anesthesia with isoflurane, rats were weighed and anesthetized 
with an intraperitoneal (i.p.) injection of a solution containing ketamine (75 μg/g body 
weight, BW) and xylazine (12 μg/g BW). Then a tracheostomy was performed and a 
10 mm polyethylene cannula inserted (ID: 0.86 mm). Rats were then placed in supine 
position on a heating mat and connected to a computer-controlled ventilator 
(flexiVent®, Scireq, Montreal, Canada) using the following settings: tidal volume 
(VT) ~8.0 mL/kg, positive end-expiratory pressure (PEEP) 5 cmH2O, respiratory rate 
(RR) 90/min, and inspired oxygen fraction (FiO2) 0.4. Lung volume history was 
standardized by two lung volume recruitment maneuvers (up to 40 cmH2O with 9-s 
ramp and 3-s plateau) within 2 min. Peak and mean airway opening pressures (Pao) 
were displayed by the flexiVent® system. Heart rate (HR) and oxygen saturation 
(SpO2) were monitored via an animal pulse oximeter (MouseOxTM, STARR Life 
Sciences CorporationTM, Oakmont, PA, USA) by placing a non-invasive sensor on the 
tail. Peak and mean Pao, HR, SpO2 and body temperature were monitored and again 
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recorded at the end of the protocol. Non-ventilated controls underwent the same 
anaesthetic and surgical procedures but were not connected to the ventilator. 
 
2.3 Allocation to study groups and experimental protocol 
Except for non-ventilated controls (n = 10 animals per group) all animals were 
ventilated for 120 min (Fig. 1). Infant rats were randomly allocated to the following 
study groups: “ventilated controls” (n = 9), i.e. mechanical ventilation without 
additional stressors applying VT ~8 mL/kg, PEEP 5, FiO2 0.4, RR 90/min, and 
constant body temperature at 38.0˚C; “acidosis” and “alkalosis” (both n = 10), i.e. 
respiratory acidosis and alkalosis induced via RR of 60/min and 180/min, 
respectively; “hypoxemia” (n = 10) and “hyperoxemia” (n = 9) induced via FiO2 of 
0.21 and 1.0, respectively; “PEEP 1” (n = 10) and “PEEP 9” (n = 9), respectively, 
where PEEP levels were regulated by the depth of the expiratory line from the 
ventilator into a water column, also, RR in the PEEP 9 group was set at 120/min in 
order to achieve normal blood gas values; “hypothermia” and “hyperthermia” (both n 
= 10) induced via body temperature of 33˚C and 41˚C, respectively; “AH” and 
“AHFR”, i.e. acute hemorrhage without (n = 8) and with subsequent fluid 
resuscitation (n = 7), respectively. Acute hemorrhage was produced after 90 min of 
protective mechanical ventilation via transcutaneous cardiac puncture and withdrawal 
of ~0.38 mL blood within 30 s. Blood volume was supposed to approximate 7% of 
body weight (Cannizzaro et al., 2010). Therefore, removing ~0.38 mL blood resulted 
in a controlled hemorrhage of ~15% estimated blood volume. Both vital and 
respiratory parameters were carefully monitored during and after this intervention. 
Animals in group “AHFR” subsequently received fluid resuscitation via i.p. 
application of ~0.75 mL saline. 
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Body temperature was controlled and kept constant by a thermocouple feedback rectal 
sensor connected to a heating mat (Physitemp Instruments, Incorporation, TCAT-2LV 
Temperature Controller, Clifton, New Jersey, USA). Before starting to collect and 
record urine output, following connection to the ventilator the bladder was emptied by 
delicately pressing on the fundus. After that, urine was either obtained via gently 
pressing on the bladder if supposed to be full or via direct bladder puncture at the end 
of the protocol. 
To avoid dehydration, all ventilated animals received i.p. 0.5 mL 0.9% saline at the 
time point 30 min. An anesthetic top-up with ketamine/xylazine was given ~15 min 
before the end of the protocol. Discomfort, stress, or pain was assessed by changes in 
heart rate, breathing efforts, and reaction to paw pinch reflex. 
 
2.4 Sampling and processing of blood for copeptin and blood gas analysis  
Before disconnecting infant rats from the ventilator blood was withdrawn directly 
from the heart following partial laparotomy and sternotomy. Few drops were used for 
blood gas analysis (i-STAT®, Axonlab, Abbott Laboratories, Illinois, USA). Blood 
gas analyses were performed in ventilated animals only. Also, cartridges for lactate 
measurements were not available for all infant rats. Hence, we focused on those 
groups where we expected significant differences when compared to ventilated 
controls, i.e. hypoxemia n = 10; hyperthermia n = 9; hypothermia n = 7; ventilated 
controls, respiratory alkalosis, and “AH”, n = 6 respectively; hyperoxemia and 
“AHFR”, n = 5, respectively; respiratory acidosis n = 4; PEEP 9 n = 3; PEEP 1 n = 2. 
The remaining blood volume was stored at 4˚C until centrifugation at 3’000 x g for 10 
min at room temperature. Plasma was then transferred in a new EDTA tube and stored 
at –80˚C until copeptin analysis. In animals from groups “AH” and “AHFR” copeptin 
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was measured twice, once from blood withdrawal at the time point 90 min and once 
30 min later, i.e. at the end of the protocol.  
 
2.5 Copeptin analysis 
Measurement of plasma copeptin was done in a single batch with a research sandwich 
immunoluminometric assay (B.R.A.H.M.S C-terminal pro-AVP luminescence 
immunoassay; B.R.A.H.M.S GmbH, Hennigsdorf, Germany). As the assay developed 
for the detection of human plasma copeptin (Morgenthaler et al., 2006) was not 
sufficiently cross-reactive with rat plasma copeptin, the tracer antibody of the assay 
was replaced by a purified sheep antibody developed against a peptide corresponding 
to amino acid positions 156-168 of rat pre-pro-vasopressin, and dilutions of a peptide 
corresponding to amino acid positions 136-168 of rat pre-pro-vasopressin were used 
as calibrators. All other assay conditions were the same as described for the human 
copeptin assay.  
 
2.6 Statistical analysis 
One-way ANOVA with Holm-Sidak post hoc tests were used for group comparisons 
of copeptin, SpO2, HR, peak and mean Pao, pH, pCO2, lactate, urine output, and 
weight. For comparison of amount of blood withdrawn to induce acute hemorrhage in 
groups “AH” and “AHFR” t-test was used. Two-way repeated measurement ANOVA 
with Holm-Sidak post hoc analysis was used to compare copeptin concentrations 
before and after acute hemorrhage in animals from groups “AH” and “AHFR”. Data 
were transformed where appropriate to ensure the assumptions of normality and equal 
variance were satisfied. Where this was not possible equivalent non-parametric 
comparisons were used. P < 0.05 was considered statistically significant. 
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3. Results 
 
3.1 Baseline values (group means) 
Between all groups no statistically significant differences were found in relation to 
body weight (34.5-38.7 g; p = 0.59), SpO2 (98.3-99.0%; p = 0.06), heart rate (281-
298/min; p = 0.84), peak Pao (11.0-12.1 cmH2O; p = 0.75), and mean Pao (7.9-8.4 
cmH2O; p = 0.59). 
 
3.2 Vital signs, ventilation parameters, blood gas, lactate, and urine output at the 
end of the study 
Values of SpO2, heart rate, peak and mean Pao, pH, pCO2, lactate, and urine output are 
shown in Table 1. Mean body temperatures in groups “hypothermia” and 
“hyperthermia” reached 32.8˚C (SD 1.6˚C) and 40.7˚C (SD 0.6˚C), respectively. 
 
3.3 Copeptin concentrations at the end of the study 
Figure 2 illustrates copeptin plasma concentrations in all mechanically ventilated 
infant rats. Except for the acute hemorrhage groups “AH” and “AHFR” (p = 0.49), we 
found statistically significant differences between all studied pairs. At the end of the 
protocol copeptin values of infant rats subjected to respiratory alkalosis, hypoxemia, 
PEEP 9, and acute hemorrhage were statistically significantly increased when 
compared to ventilated controls.  
 
3.4 Copeptin response following acute hemorrhage 
Figure 3A shows copeptin values before and 30 min after induction of acute 
hemorrhage. The amount of blood withdrawn was similar between groups, i.e. 0.38 
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mL (SD 0.04 mL) and 0.39 mL (SD 0.05 mL) in groups “AH” and “AHFR”, 
respectively (p = 0.85). The copeptin rise was statistically significant and independent 
of subsequent fluid resuscitation. 
 
3.5 Copeptin half life 
Figure 3B demonstrates the course of copeptin based on plasma concentrations 
obtained at the time points 0, 90, and 120 min. Copeptin levels in non-ventilated rats 
were ~10-fold higher when compared to ventilated controls (median value of 227 
pmol/L versus 22 pmol/L). Non-ventilated controls underwent anesthesia, 
tracheostomy, and intubation without mechanical ventilation at the time point 0 min. 
Groups “AH” and “AHFR” were protectively ventilated up to the time point 90 min 
where blood was withdrawn to induce acute hemorrhage. Lastly, infant rats from the 
ventilated control group were mechanically ventilated throughout the protocol without 
any additional stressor. Copeptin concentrations significantly decreased over time. 
Based on the mean concentrations of our 3 time points and the following formula: T 
½ = (log 2 x elapsed time) / log (concentration at the beginning / concentration at the 
end), we calculated a half life ranging from 23-47 min. 
 
3.6 Copeptin and gender 
Gender comparison revealed no statistically significant difference between all studied 
groups (p in all cases > 0.11), except for acute hemorrhage without fluid resuscitation 
(AH) where females showed higher copeptin levels (p = 0.044). However, it needs to 
be mentioned that this difference is based on comparison of 3 males and 5 females 
only. 
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4. Discussion 
Our results demonstrate that knowledge of potential stressors is mandatory in order to 
interpret the sensitive and early responsive biomarker copeptin. Using an in vivo 
infant rat model we were able to both standardise protocols and systematically 
examine some of the commonly occurring stressors in intensive care units. Also, to 
the best of our knowledge, this is the first study detecting plasma rat copeptin 
concentrations quantitatively. Our major findings are summarised as follows: first, 
non-osmotic stimuli such as respiratory alkalosis, hypoxemia, and acute hemorrhage 
produced significant copeptin responses, whereas respiratory acidosis, hyperoxia, and 
changes in body temperature did not; second, non-injurious mechanical ventilation 
per se did not stimulate copeptin release; and third, supposedly unstressed non-
ventilated controls showed clearly increased copeptin values.  
 
Acidosis has been considered a stimulus for AVP release (Holmes et al., 2001). In our 
study, the role of pH was investigated via induction of hyper- and hypocapnia. For 
two main reasons we decided to alter pH by ventilation only. First, respiratory 
acidosis and alkalosis can be achieved easily and rapidly in artificially ventilated 
animals. Second, relevant metabolic compensation is unlikely to occur within 2 h. 
Acidosis as a stimulus for AVP release originates from the work by Wood and Chen 
(1989) who used an i.v. infusion of hydrochloric acid to induce metabolic acidosis in 
fetal sheep. Later studies (Rose et al., 1984; Raff et al., 1991) presented a correlation 
between hypercapnic acidosis and AVP, however only in combination with 
hypoxemia. Based on our study results we question whether there is enough evidence 
to support that both acidosis and hypercapnia (without hypoxemia) play a key role in 
AVP release. In contrast to our hypothesis, we found that hypocapnic alkalosis caused 
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a significant increase of copeptin. As to the association between copeptin and 
hypocapnic alkalosis we can only speculate since the finding was unexpected and to 
our knowledge not studied so far. The mild but significant increase in lactate in the 
context of (normoxic) hypocapnic alkalosis is well-known (Eldridge and Salzer, 
1967) and unlikely the cause of the observed copeptin increase. From a physiological 
point of view, hypocapnia induces cerebral vasoconstriction with a subsequent 
decrease in cerebral blood flow. Whether hypocapnia of ~3.5 kPa, as in our model, 
was sufficient to produce significant cerebral ischemia remains unclear, but could 
provide a possible explanation for copeptin elevation (Katan et al., 2009). 
 
As hypothesised, hypoxemia resulted in a significant copeptin increase. This finding 
was in line with previous studies reporting major AVP release following normo- and 
hypercapnic hypoxemia (Anderson et al., 1978; Smith et al., 1995). In fact, 
hypoxemia can be considered a powerful stressor compromising homeostatic balance. 
Afferents from chemo- and baroreceptors are supposed to mediate AVP release via 
activation of both hypothalamic-pituitary-adrenal (HPA) axis and sympathetic 
nervous system (Anderson et al., 1978; Schrier et al., 1979; Leng et al., 1999; 
Goldstein and Kopin, 2008). 
 
Based on the fact that positive pressure ventilation alters hemodynamics and renal 
function (Pannu and Mehta, 2007) we hypothesised that any ventilation strategy 
would increment AVP release. In order to investigate the impact of mechanical 
ventilation on AVP response we applied a protective ventilation strategy. In addition, 
we used two strategies with lower and higher positive end-expiratory pressure (PEEP) 
to mimic particularly low and high intrathoracic pressures (ITP), respectively. As 
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opposed to our hypothesis, artificial ventilation per se did not stimulate AVP. 
However, application of high PEEP resulting in elevated peak and mean airway 
opening pressures, and hence increased ITP, produced a significant copeptin rise. This 
finding is important and clinically relevant since ventilation with high PEEP levels is 
frequently applied as part of the “open lung” strategy. From a physiological point of 
view our result can be explained as follows. Mechanical ventilation with high PEEP 
increases both ITP and lung volume. ITP reduces venous return to the right atrium. At 
the same time, increased airway pressure raises extraluminal pressure of alveolar 
capillaries resulting in elevated right ventricular afterload. Consequently, right and 
left sided stroke volumes decrease (Feihl and Broccard, 2009). This hemodynamic 
change is then detected by low (atria and ventricles) and high (aorta and carotis) 
pressure mechanoreceptors. Decrease in preload and blood pressure “unloads” these 
receptors hereby increasing AVP secretion via afferent signals to the HPA axis 
(Koyner and Murray, 2010). Furthermore, significantly reduced urine output can be 
attributed to a neurohumoral response where increased sympathetic tone and 
activation of the renin-angiotensin-axis lead to decreased renal blood flow and 
eventually oliguria. 
 
Similarly to hypoxemia, severe hyper- and hypothermia are intense threats to 
homeostasis. Also, a potential role of AVP in rat thermoregulation has been suggested 
by Jasnic et al. (2010). In the critical care context hyperthermia is often encountered 
in association with inflammation, infection, or drugs, while controlled hypothermia 
has become a therapeutic approach, e.g. following cardiac arrest in adults or hypoxic-
ischemic encephalopathy in newborns. In our model we were able to produce 
significant tachycardia and bradycardia in hyperthermia and hypothermia groups, 
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respectively (Table 1). Though we found small but statistically significant differences 
in copeptin plasma concentrations between hyper- and hypothermia, no copeptin 
differences were found when compared to the ventilated normothermic controls (Fig. 
2). It is conceivable that externally induced hyperthermia cannot be compared to 
infection-induced fever in terms of homeostatic threat. Additionally, it is possible that 
our hyperthermia model was inadequate to induce physiologically relevant alterations 
since significant dehydration with decreased urine output (Table 1) and subsequent 
AVP/copeptin release did not occur. On the other hand, unaltered copeptin 
concentrations in response to severe hypothermia corroborate clinical findings 
obtained in neurosurgical adult patients showing no effect of hypothermia on AVP 
level (Chi et al. 2001). These findings suggest that in both anesthetised rats and 
humans, moderate to severe hypothermia is not a relevant stressor for AVP/copeptin 
release. 
 
AVP is essential in maintaining blood pressure. Changes in blood volume or pressure 
have previously been shown to strongly activate AVP release (Bisset and Chowdrey, 
1988; Leng et al., 1999; Morgenthaler et al., 2007). As expected, in our model 
moderate hemorrhage accompanied by a significant rise of lactate caused a rapid jump 
in copeptin concentration. Similarly to the high PEEP-related change in 
hemodynamics, presumably relaxation of low and high pressure mechanoreceptors in 
the heart chambers and aortic arch / carotid body, respectively, played a major role. 
These cardiovascular receptors most likely led to an alteration of discharge rate 
resulting in a stress response via afferent fibres to the HPA axis (Bisset and 
Chowdrey, 1988). In contrast to our hypothesis, immediate fluid resuscitation did not 
mitigate early copeptin response. This finding probably reflects the fact that a 
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powerful and life threatening stimulus activating the stress response-cascade cannot 
be reversed or weakened in an early phase. 
 
Copeptin concentrations measured in non-ventilated control groups were completely 
unexpected. What distinguishes non-ventilated infant rats from all other groups is the 
time point of blood withdrawal. In other words, though we did not measure copeptin 
in ventilated infant rats at the time point 0 min, it is conceivable that due the strict 
study protocol, i.e. animal handling and preparation, these animals experienced 
similar emotional stress before group allocation and ventilation. Moreover, protective 
mechanical ventilation under anesthesia and without additional stressors for 120 min 
offered an opportunity to investigate copeptin half life. 
On average, pups were separated from their dam and littermates for ~30 min 
before starting inhalational anesthesia followed by i.p. anesthesia and subsequent 
blood withdrawal. A surgical procedure can be excluded as cause of elevated copeptin 
at the time point 0 min since blood withdrawal occurred after i.p. anesthesia. 
Moreover, we cannot exclude that pharmacological agents may have influenced 
copeptin concentration. On the other hand, anesthetic top-ups applied ~15 min before 
the end of the protocol did not result in copeptin increase. Furthermore, animal 
handling was done by experienced persons in compliance with accepted international 
guidelines. Though there is enough evidence showing that “stress” has the potential to 
activate the HPA axis and sympathetic nervous system (Charmandari et al., 2005; 
Goldstein and Kopin, 2008), it was not evident to us that our infants rats were 
exposed to emotional stress. However, when taking into account that both maternal 
separation and exposure to an unknown environment is undoubtedly stressful we 
might have to reconsider the concept of expected versus perceived emotional stress. 
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Given that infant rats experienced a rather short period of “stress”, one is tempted to 
speculate that the perceived stress must have been major. If this assumption holds true 
there might be implications for animal handling and studies in the field of emotional 
stress response perhaps requiring longer adaptation training and time. 
 
Recently, it has been argued that gender has to be taken into consideration when 
interpreting copeptin levels. Bhandari et al. (2009) found higher copeptin 
concentrations in healthy male volunteers when compared with females. In our study, 
we did not find significant correlations between gender and copeptin. Given the major 
differences in study design and age (adult human vs infant rat), and severity of disease 
(healthy volunteers vs “sick” infants), it is virtually impossible to draw conclusions 
for clinical practice. 
 
The following study limitations have to be acknowledged. Like all models of disease, 
results from a rat model can only cautiously be extrapolated to humans. On the other 
hand, strict standardisation and investigation of “single” factors can only be achieved 
by an in vivo animal model. In terms of rat-adjusted copeptin assay, we have to 
acknowledge that as opposed to human studies we did not measure AVP in parallel 
with copeptin. To correct this shortcoming, future rat studies should correlate 
copeptin with AVP. Due to our experimental set-up it remains unclear whether the 
copeptin elevation in hypocapnic alkalosis is attributable to pH or hypocapnia. 
Investigating the impact of metabolic alkalosis on copeptin was beyond the scope of 
this study, but might be an interesting starting point for future studies. In terms of 
model selection it might have been helpful to induce fever in addition to our 
hyperthermia model where heat was applied externally. Moreover, measurement of 
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plasma osmolarity and electrolytes might have provided useful information regarding 
status of dehydration. As to the hemorrhage model we did not measure blood pressure 
to objectify response to both blood withdrawal and fluid resuscitation. However, we 
are confident that hemodynamic changes were significant since we observed a 
hyperacute and temporary loss of SpO2 in all animals. Moreover, in order to 
differentiate between endocrine and emotional stress (Katan and Christ-Crain, 2010), 
we propose that future studies additionally measure cortisol concentration in plasma 
or urine. Lastly, due to the protocol duration we were not able to perform serial 
copeptin measurements allowing documentation of its dynamics and longer-term 
course. 
 
In conclusion, we have shown that copeptin is significantly influenced by respiratory 
alkalosis, hypoxemia, high PEEP, hemorrhage, and psycho-emotional stress. 
Moreover, in contrast to previous studies we cannot confirm a direct association 
between copeptin and acidosis, hypercapnia, and hyperthermia. Physicians working in 
the acute critical care setting should be aware of these factors when interpreting 
copeptin plasma concentrations. Finally, our results do have implications for animal 
studies in the field of stress research.  
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8. Figure legends 
Figure 1 
Experimental set-up illustrating the sequence of animal preparation and time points of 
interventions and blood withdrawal. 
 
Figure 2 
Copeptin plasma concentrations in ventilated study groups. All animals were 
mechanically ventilated for 120 min. Data are presented as simple error bars with 
median, 25th, and 75th percentiles. * indicates significant differences compared to 
ventilated control groups only; # shows significant differences between pairs, e.g. 
respiratory acidosis versus alkalosis. 
 
Figure 3 
Panels A and B show copeptin plasma concentrations plotted against different time 
points. Data are displayed as vertical box plots with median, 10th, 25th, 75th, and 90th 
percentiles. Infant rats in group “AH” and “AHFR” were treated as “ventilated 
controls” up to the time point of 90 min, where acute hemorrhage (AH) was induced 
in both groups. Subsequently, only rats from group “AHFR” received fluid 
resuscitation. Both plasma obtained from induction of AH (time point 90 min) and 
plasma obtained 30 min later, i.e. at the time point 120 min, was used to measure 
copeptin. Panel A demonstrates a statistically significant increase of copeptin 
following AH. Fluid resuscitation had no impact on copeptin response (p = 0.82). 
Panel B displays copeptin half life. 
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Table 
 
Table 1 
SpO2, heart rate, peak and mean airway opening pressure (Pao), pH, pCO2, lactate, and 
urine output after 120 min of mechanical ventilation 
 
 
Groups SpO2 
Heart 
Rate 
Peak Pao 
(cmH2O) 
Mean Pao 
(cmH2O) 
pH pCO2 (kPa) 
Lactate 
(mmol/L) 
Urine 
(mL) 
Ventilated controls 98.5 (0.5) 292 (17) 12.3 (0.8) 8.4 (0.3) 7.42 (0.03) 5.2 (0.3) 0.8 (0.2) 0.3 (0.2) 
Respiratory acidosis 98.2 (0.8) 281 (23) #11.4 (0.6) *,#7.8 (0.3) *,#7.25 (0.08) *,#8.0 (1.4) #0.7 (0.2) 0.3 (0.1) 
Respiratory alkalosis 98.5 (0.5) 306 (18) #12.9 (1.1) *,#9.1 (0.5) *,#7.54 (0.07) *,#3.5 (0.7) *,#2.4 (1.1) 0.2 (0.1) 
Hypoxemia *77.6 (12.6) 297 (17) 12.0 (0.9) 8.3 (0.4) 7.39 (0.07) 5.2 (0.8) *,#2.0 (0.6) 0.3 (0.2) 
Hyperoxia 98.9 (0.4) 291 (19) 12.8 (1.1) 8.7 (0.5) 7.38 (0.06) 6.1 (1.2) #0.8 (0.2) 0.3 (0.2) 
PEEP 1 98.3 (0.2) 296 (13) *,#10.0 (1.2) *,#5.4 (0.5) 7.42 (0.03) 5.0 (0.3) 0.9 (0.1) #0.5 (0.2) 
PEEP 9 98.6 (0.5) 284 (25) *,#18.6 (0.5) *,#13.4 (0.2) 7.41 (0.05) 4.9 (0.5) 1.1 (0.3) #0.1 (0.1) 
Hypothermia 98.6 (0.6) *,#230 (43) #11.3 (0.8) #8.0 (0.3) 7.37 (0.07) 6.2 (1.2) 0.6 (0.1) 0.3 (0.2) 
Hyperthermia 98.2 (0.8) #323 (20) #12.7 (0.8) #8.6 (0.4) *7.30 (0.05) 5.9 (1.1) #1.5 (0.7) 0.2 (0.1) 
Acute hemorrhage (AH) 98.6 (0.6) 281 (19) 12.8 (0.6) 8.7 (0.3) 7.33 (0.09) 5.2 (0.9) *4.5 (1.6) 0.2 (0.1) 
AH with fluids 97.9 (1.7) 275 (14) 13.2 (1.1) 8.8 (0.5) 7.32 (0.04) 5.0 (0.9) *4.5 (2.0) 0.2 (0.1) 
Data are expressed as group means ± standard deviation. * indicates statistically 
significant differences compared to ventilated controls only; # indicates statistically 
significant differences between pairs.  
 
 1
